| Literature DB >> 34560835 |
Dan Wang1, Juan Xu1, Xiao-Lin Yang2, Yan-Xia Guo1, Ping-Ping Jiang1, Guo-Yuan Zhang3.
Abstract
BACKGROUND: To investigate the effects of different plasma target concentrations of remifentanil on the minimum alveolar concentration (MAC) for blocking adrenergic response (BAR) of sevoflurane in children with laparoscopic herniorrhaphy.Entities:
Keywords: Children; Minimum alveolar concentration (MAC); Pneumoperitoneum stimulus; Remifentanil; Sevoflurane
Mesh:
Substances:
Year: 2021 PMID: 34560835 PMCID: PMC8461836 DOI: 10.1186/s12871-021-01453-z
Source DB: PubMed Journal: BMC Anesthesiol ISSN: 1471-2253 Impact factor: 2.217
Fig. 1Flowchart of the patient selection and analysis process for the study. In this study,75 patients were randomly allocated into 3 groups with 25 patients in each group. To obtain six crossover points of positive vs. negative response in each group, 18, 13 and 19 (not shown the 2 cases for discontinue intervention due to hypotension) patients in groups R0, R1 and R2 were needed respectively. Finally, remaining 23 patients did not undergo the experimental intervention
Fig. 2The measurement of MACBAR of sevofluane in 3 groups. The plasma target concentration of remifentanil in groups R0, R1 and R2 was 0, 1 and 2 ng ml-1, respectively. An empty (solid) circle represents a negative (positive) reaction to hemodynamic parameters, and a triangle indicates an intersection of a negative reaction with a positive reaction. To get six crossovers, 18, 13 and 19 patients (not shown the 2 cases for withdrawn) were needed in groups R0, R1 and R2, respectively
The comparison of patients’ characteristics, delta HR, delta MAP, delta E, and delta NE among three groups. The data of 2 cases that were withdrawn from group R2 were not included in this table. Values are presented as mean ± SD or n. The baseline value of each parameter was the average value measured 3 and 1 min before CO2 pneumoperitoneum. The value of delta represents the difference between before and after pneumoperitoneum stimulation. HR, heart rate; MAP, mean arterial pressure; E, epinephrine concentration; NE, norepinephrine concentration. #P < 0.05, compared with group R0; * P < 0.05, compared with group R1
| Parameter | Group R | Group R | Group R | P values | |||
|---|---|---|---|---|---|---|---|
| R0&R1&R2 | R0&R1 | R0&R2 | R1&R2 | ||||
| Age (years) | 4.6 ± 1.0 | 5.5 ± 1.1 | 4.9 ± 1.0 | 0.147 | 0.055 | 0.553 | 0.156 |
| Body weight (kg) | 17.1 ± 2.5 | 18.3 ± 2.2 | 17.5 ± 2.1 | 0.359 | 0.188 | 0.901 | 0.222 |
| Male/Female (n) | 16/2 | 12/1 | 16/3 | 0.912 | 0.802 | 0.968 | 0.833 |
| MACBAR (%) | 3.29 ± 0.17 | 2.12 ± 0.10# | 1.29 ± 0.11#* | 0.000 | 0.000 | 0.000 | 0.000 |
| Baseline HR (bpm) | 135 ± 13 | 106 ± 15 # | 94 ± 11 # | 0.000 | 0.000 | 0.000 | 0.026 |
| Delta HR | 9 ± 12 | 7 ± 13 | 8 ± 5 | 0.863 | 0.595 | 0.732 | 0.849 |
| Baseline MAP (mmHg) | 68 ± 5 | 59 ± 2 # | 54 ± 6 # | 0.000 | 0.000 | 0.000 | 0.013 |
| Delta MAP | 8 ± 6 | 11 ± 10 | 13 ± 9 | 0.344 | 0.362 | 0.151 | 0.589 |
| Baseline E (ngml-1) | 2.20 ± 0.63 | 2.10 ± 0.80 | 2.05 ± 0.91 | 0.900 | 0.764 | 0.655 | 0.883 |
| Delta E | 0.20 ± 1.23 | 0.33 ± 0.95 | -0.06 ± 1.21 | 0.693 | 0.787 | 0.572 | 0.405 |
| Baseline NE (pgml-1) | 540.30 ± 65.64 | 498.40 ± 61.66 | 464.09 ± 76.91 | 0.373 | 0.453 | 0.164 | 0.510 |
| Delta NE | 65.31 ± 20.75 | 56.24 ± 21.01 | 52.85 ± 24.37 | 0.368 | 0.297 | 0.181 | 0.706 |